Twitter has Subpoenaed Information about Investors Chamath Palihapitiya, David Sacks and Steve Jurvetson
-Washington Post
https://www.washingtonpost.com/technology/2022/08/01/musk-twitter-subpoena/
Trump Endorses ‘ERIC’ For Missouri Senate Race, But Will The Real Candidate Please Stand Up?
Donald Trump has spurred confusion in his signature style with his endorsement for 'ERIC' in Missouri’s GOP Senate primary, with two rival candidates with the same first name laying claim to the former U.S. President's statement of support.
Does Being On Facebook Make You Richer? Here’s What Meta’s Research Says
Meta Platforms Inc (NASDAQ: META) run Facebook says its “years-long” research with economist Raj Chetty’s Opportunity Insights has led it to conclude that “social connections” play an important role in economic mobility.
Pelosi Effect? Why Key Apple Supplier TSMC’s Shares Are Slipping Today
Shares of chipmaker Taiwan Semiconductor Mfg. Co. Ltd. (NYSE: TSM) fell as much as 2.98% in Asia trading on Tuesday after China expressed anger at reports of U.S. House Speaker Nancy Pelosi making a possible trip to Taiwan later in the day.
So Which Will Happen First, Ethereum At $10K Or Dogecoin At $0.50? 6 In 10 Say…
Every week, Benzinga conducts a survey to collect sentiment on what traders are most excited about, interested in or thinking about as they manage and build their personal portfolios.
Recap Of Monday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application…
PepsiCo Isn’t The Only One Bullish On Celsius: This Analyst Explains Why It’s A Good Bet
Celsius Holdings, Inc. (NASDAQ: CELH) jumped nearly 12% higher on Monday after the announcement of it entering a long-term distribution partnership with soft-drink behemoth PepsiCo, Inc. (NASDAQ: PEP), a move that analys
Aerie Shares Gain Following Patient Dosing In Late-Stage Dry Eye Disease Study
Aerie Pharmaceuticals (NASDAQ: AERI) has initiated patient dosing in the Phase 3 registrational COMET-3 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).
Activision Blizzard Q2 Earnings: Here’s A Rundown Of The Results
Activision Blizzard Inc (NASDAQ: ATVI) announced its second-quarter financial results Monday after the bell. Here's a look at how the video game company fared during the quarter.
Revlon Obtains Court Approval For $1.4B Bankruptcy Loan: Reuters
Cosmetics company Revlon Inc (NYSE:REV) has received a U.S. bankruptcy judge’s permission to proceed with a $1.4 billion loan, Reuters reported.…